Cue Biopharma to Host Business Update Call and Webcast
BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq:CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate tumor-specific T cells directly within the patient’s body, announced today that it will host a conference call and webcast to provide a business update on Monday, November 14, 2022 at 4:30 p.m. EST. Live and archived versions of the event can be accessed via the Company’s website.
Related news for (CUE)
- Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/16/25 12:00 PM
- 24/7 Market News Snapshot 16 July, 2025 – Cue Biopharma, Inc. (NASDAQ:CUE)
- Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
- Cue Biopharma to Host Virtual Investor Event on May 15, 2025